scholarly journals Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial

The Prostate ◽  
2009 ◽  
Vol 70 (6) ◽  
pp. 584-590 ◽  
Author(s):  
Alan R. Kristal ◽  
Douglas K. Price ◽  
Cathee Till ◽  
Jeannette M. Schenk ◽  
Marian L. Neuhouser ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Benign Prostatic Hyperplasia ◽  
Cancer Prevention ◽  
Prostatic Hyperplasia ◽  
Repeat Length ◽  
Cag Repeat ◽  
Prevention Trial ◽  
Symptomatic Benign Prostatic Hyperplasia ◽  
Prostate Cancer Prevention

scholarly journals Androgen Receptor CAG Repeat Length and TMPRSS2:ETS Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial

Urology ◽  
2014 ◽  
Vol 84 (1) ◽  
pp. 127-131 ◽  
Author(s):  
William D. Figg ◽  
Cindy H. Chau ◽  
Douglas K. Price ◽  
Cathee Till ◽  
Phyllis J. Goodman ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Cancer Risk ◽  
Cancer Prevention ◽  
Prostate Cancer Risk ◽  
Repeat Length ◽  
Cag Repeat ◽  
Prevention Trial ◽  
Prostate Cancer Prevention ◽  
Prostate Cancer Prevention Trial
Sign in / Sign up

Export Citation Format

Share Document